The stock of Enveric Biosciences Inc (ENVB) has gone down by -21.24% for the week, with a -38.62% drop in the past month and a -42.95% drop in the past quarter. The volatility ratio for the week is 8.21%, and the volatility levels for the past 30 days are 15.96% for ENVB. The simple moving average for the past 20 days is -27.88% for ENVB’s stock, with a -52.98% simple moving average for the past 200 days.
Is It Worth Investing in Enveric Biosciences Inc (NASDAQ: ENVB) Right Now?
The stock has a 36-month beta value of 0.84. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ENVB is 6.03M, and at present, short sellers hold a 2.49% of that float. On April 02, 2024, the average trading volume of ENVB was 4.39M shares.
ENVB) stock’s latest price update
Enveric Biosciences Inc (NASDAQ: ENVB)’s stock price has dropped by -11.00 in relation to previous closing price of 1.00. Nevertheless, the company has seen a loss of -21.24% in its stock price over the last five trading days. InvestorPlace reported 2024-02-29 that Biotech investors know that small companies can make massive moves on big headlines, and we’re seeing such a move in Enveric Biosciences (NASDAQ: ENVB ) today. Shares of ENVB stock are up more than 120% in early afternoon trading today after the company put forward a press release highlighting plans to license three classes of its compounds.
ENVB Trading at -13.44% from the 50-Day Moving Average
After a stumble in the market that brought ENVB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -87.25% of loss for the given period.
Volatility was left at 15.96%, however, over the last 30 days, the volatility rate increased by 8.21%, as shares sank -46.39% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -16.82% lower at present.
During the last 5 trading sessions, ENVB fell by -21.24%, which changed the moving average for the period of 200-days by -77.06% in comparison to the 20-day moving average, which settled at $1.1955. In addition, Enveric Biosciences Inc saw -31.54% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ENVB starting from PASQUALONE FRANK, who purchase 1,000 shares at the price of $2.14 back on Sep 15 ’23. After this action, PASQUALONE FRANK now owns 1,000 shares of Enveric Biosciences Inc, valued at $2,140 using the latest closing price.
Stock Fundamentals for ENVB
The total capital return value is set at -4.36. Equity return is now at value -187.69, with -134.87 for asset returns.
Currently, EBITDA for the company is -16.04 million with net debt to EBITDA at 0.15. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.29.
Conclusion
To sum up, Enveric Biosciences Inc (ENVB) has seen a bad performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
